In recent years, the term “exosome” has frequently appeared in content related to regenerative medicine, tissue repair, skin applications, and chronic wounds. However, the growing popularity of this concept has also led to several important misconceptions.
Exosomes are biologically significant structures that have attracted considerable scientific interest. However, the term “exosome” does not refer to a standardized treatment that can be used for every disease, has the same characteristics in every product, or can guarantee healing on its own.
In this article, we will explain in clear language what exosomes are, what they are not, and why they cannot replace an accurate diagnosis and established treatments, particularly in chronic wounds.
What Is an Exosome?
Exosomes are one type of very small extracellular vesicle released by cells into their surroundings. They are enclosed by a lipid membrane similar to the cell membrane. They may contain proteins, lipids, and certain molecules that carry genetic information.
These small structures are considered part of the communication system between cells. In simple terms, exosomes can be thought of as biological message packages sent from one cell to another.
There is an important scientific distinction: not every extracellular vesicle is an exosome. Extracellular vesicles are a broad group of structures with different mechanisms of formation. Small size alone is not sufficient for a structure to be technically classified as an “exosome.” Its pathway of formation within the cell must also be demonstrated.
For this reason, the broader terms “extracellular vesicle” or “EV” are often preferred in scientific publications. For detailed information on terminology, production processes, and characterization standards, the MISEV2023 guidelines published by the International Society for Extracellular Vesicles may be reviewed.
Are Exosomes and Stem Cells the Same Thing?
No. An exosome is not a stem cell.
A stem cell is a living cell. Under certain conditions, it can proliferate, differentiate into various cell types, and actively interact with its environment.
An exosome, by contrast, is not a cell. It is a small membrane-bound biological structure released by a cell. It cannot reproduce or transform into a new cell.
Because some exosome studies examine extracellular vesicles obtained from stem cells, the two concepts are sometimes used interchangeably. However, “stem cells” and “exosomes” are not biologically the same thing.
To review the fundamental concepts of regenerative approaches together, you can read our guide to regenerative medicine, PRP, exosomes, and tissue repair .
What Is an Exosome Not?
One of the most practical ways to understand exosomes correctly is to know what they are not.
Exosomes are not a miraculous treatment for every disease
Promising results observed in a laboratory setting do not mean that a biological mechanism has become an effective and standardized treatment for every patient.
Scientific research potential, clinical trial findings, and routine clinical practice are different concepts. This distinction should not be overlooked.
Exosome is not a product brand
“Exosome” is not the name of a single medication or a single standardized product. Cell source, production process, isolation method, content analysis, quality-control steps, storage conditions, and traceability may all affect the final product.
Therefore, the presence of the word “exosome” on a package does not mean that different products are equivalent.
Exosomes are not an alternative to established treatments
Especially in chronic wounds, it is not appropriate to focus solely on a supportive product without first evaluating key issues such as impaired circulation, venous insufficiency, edema, infection, diabetes control, neuropathy, and pressure load.
For detailed information about the fundamental approach to non-healing wounds, you can review our chronic wound treatment page and our guide explaining why chronic wounds do not heal .
Exosomes are not ordinary serums that can be assumed to be risk-free
For biological products intended for use in the human body, the source, manufacturing conditions, microbiological safety, quality control, and traceability are critically important. A product is not automatically safe simply because it is natural or biologically derived.
The United States Food and Drug Administration (FDA) has issued a public safety notification regarding the marketing of unapproved exosome products with unsupported claims that they can prevent, treat, or cure diseases. The FDA also updated its warnings regarding human cell- and tissue-based products in 2026.
These warnings do not automatically determine the status of every product in other countries. However, they clearly demonstrate why quality control, regulatory compliance, and patient safety are essential for biological products.
Why Are Exosomes Being Studied Scientifically?
Extracellular vesicles are thought to play a role in communication between cells. Researchers are therefore investigating their effects on inflammation, immune responses, blood vessel formation, tissue regeneration, and different stages of wound healing.
Wound healing is not a single-step process. It consists of interconnected stages such as hemostasis, inflammation, new tissue formation, and tissue remodeling.
Exosomes and other extracellular vesicles are being studied because of their potential roles in these biological processes. Clinical trials evaluating different products and methods of administration in chronic wounds are also ongoing. For example, a pilot study evaluating the topical use of exosomes derived from human adipose tissue is registered in the ClinicalTrials.gov database.
The presence of clinical trials demonstrates strong scientific interest. However, this does not mean that every product under investigation has sufficient evidence for routine clinical use.
For an overview of approaches aimed at tissue repair, you can review our regenerative medicine page.
What Is the Main Question in Chronic Wounds?
For a wound that does not heal, the first question should not be, “Which product should we use?”
The first question should be:
Why is this wound not healing?
A chronic wound may have several underlying causes:
- Insufficient arterial blood flow
- Venous insufficiency and increased venous pressure
- Significant swelling of the leg
- Diabetes-related nerve damage
- Infection
- Continuous pressure on the foot or a specific area
- Inadequate wound care
- Malnutrition
- The simultaneous presence of more than one contributing factor
Particularly in leg and foot wounds, it is not sufficient to examine only the surface of the wound. Blood flow, edema, signs of infection, and the underlying cause of the wound must be evaluated together.
Interventions performed without an accurate diagnosis may delay effective treatment.
What Is the Priority in Wounds Caused by Arterial Blockage?
Arteries carry oxygen and nutrients to the tissues. If there is severe narrowing or blockage in the arteries of the leg, even a small foot wound may be difficult to heal.
If the foot is cold, calf pain occurs while walking, foot pain worsens at night, or the toes become bluish or black, blood flow should be assessed before wound care or at the same time as wound care.
In a wound with insufficient blood flow, focusing only on topical treatments is not enough. For detailed information, you can read our guide to foot wounds caused by arterial blockage .
Why Is Compression Important in Venous Ulcers?
When the valves in the veins do not function properly, blood can pool in the legs. Over time, increased venous pressure may lead to edema, darkening of the skin, hardening of the tissues, and open wounds around the ankle.
These wounds are called venous ulcers.
In venous ulcers, dressings alone are generally not sufficient. In appropriate patients, compression therapy, edema control, wound care, and evaluation of the underlying venous insufficiency are required.
The NHS identifies compression bandaging applied by a trained healthcare professional as one of the main treatments for venous leg ulcers. For detailed information, you can review the NHS guide to venous leg ulcer treatment.
Our related patient guides:
- What is a venous ulcer? Symptoms and compression therapy
- What do compression stockings do? Choosing the correct pressure and size
What Should Be Considered in Diabetic Foot Ulcers?
Over time, diabetes can affect both the nerves and the blood vessels. When nerve damage develops, a patient may not notice a small cut, blister, callus, or irritation caused by footwear.
If circulation is also impaired, a wound may become infected more easily and may be more difficult to heal.
The CDC recommends that people with diabetes inspect their feet every day for cuts, redness, swelling, wounds, blisters, and calluses. Detailed recommendations are available on the CDC diabetes and foot health page .
What Questions Should Be Asked About a Biological Product?
Before deciding on a product or procedure, it is important to answer the following questions:
- What is the source of the product?
- How are the manufacturing and quality-control processes carried out?
- Which methods have been used to analyze its contents?
- What are the storage and transportation conditions?
- Is the product traceable?
- For which clinical purpose is it being considered?
- What established and evidence-based treatments are available for this purpose?
- What are the alternative approaches?
- What are the potential risks and uncertainties?
- Does the procedure comply with the relevant regulations and authorization requirements?
A scientific approach requires an open discussion not only of potential benefits, but also of limitations, risks, and alternatives.
Frequently Asked Questions
Do exosomes contain stem cells?
Exosomes are not stem cells. They are small biological structures released by cells. The product’s contents, source, and characterization must be evaluated separately.
Can exosomes heal every wound?
No. No product can be expected to work in every wound without identifying the cause of the chronic wound. Factors such as arterial blood flow, venous insufficiency, edema, infection, diabetes, and pressure must be evaluated.
Can exosomes open blocked arteries?
Exosomes should not be considered a method for opening blocked arteries. In patients with suspected arterial blockage, blood flow should be evaluated through a clinical examination and the necessary vascular investigations.
Why is exosome quality important?
Biological structures referred to as exosomes may differ in their source, manufacturing method, isolation process, content analysis, storage conditions, and traceability. Standardization and quality control are therefore important.
What should be done for a non-healing wound on the leg or foot?
For wounds that have not healed for a long time, changing the dressing alone may not be sufficient. The underlying circulatory problem, infection, edema, and other contributing factors should be evaluated together.
Conclusion
Exosomes are biological structures involved in communication between cells and are attracting considerable scientific interest. However, exosomes are not stem cells, not every product is the same, and they should not be regarded as a proven solution for every disease.
Especially in chronic wounds, the correct approach is to identify the underlying cause of the wound, evaluate circulation, and plan established treatments comprehensively.
When following scientific developments, maintaining a clear distinction between hope and evidence is essential for patient safety.
Author: Op. Dr. Kadir Çeviker
Specialty: Cardiovascular Surgery Specialist
Last updated: June 11, 2026
This text has been prepared for general informational purposes. It is not intended as a diagnosis or personalized treatment recommendation.
References
- Welsh JA et al. MISEV2023: Minimal information for studies of extracellular vesicles. Journal of Extracellular Vesicles, 2024.
- International Society for Extracellular Vesicles — MISEV Guidelines
- FDA — Public Safety Notification on Exosome Products
- FDA — Patient and Consumer Warning About Potential Serious Risks Following Use of Unapproved Human Cell or Tissue Products
- ClinicalTrials.gov — Pilot Study of Human Adipose Tissue-Derived Exosomes for Healing of Chronic Wounds
- CDC — Your Feet and Diabetes
- NHS — Venous Leg Ulcer Treatment
